Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

FHS
June 3, 2024
11:36 am

Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).

Commercial Drug Manufacturing Companies | Pharma Industry

Commercial dose companies form a critical component of the pharmaceutical manufacturing industry’s value chain. Commercial dose form manufacturing follows API manufacturing to produce the final

September 20, 2024

SPG-15: A Mother’s Fight for a Gene Therapy Cure, Maddi’s Story

News Medical spoke to the CEO and founder of the Maddi Foundation to gain a patient perspective on how important research in gene therapy is.

July 3, 2023

US negotiations for first round of drugs reveal $6bn in Medicare savings – Pharmaceutical Technology

The Biden Administration had announced the price cuts that were negotiated by the Centers for Medicare and Medicaid Services (CMS) for the first ten selected

August 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.